Doç. Dr. Özlem Doğan

Eğitim ve Uzmanlık

• 2006-2013 Karadeniz Teknik Üniversitesi Tıp Fakültesi
• 2013-2018 Haseki Eğitim ve Araştırma Hastanesi İç Hastalıkları Uzmanlık
• 2020-2024 Ankara Etlik Şehir Hastanesi Tıbbi Onkoloji Yandal Uzmanlığı

Deneyim

• Suluova Devlet Hastanesi, İç Hastalıkları
• Adıyaman Üniversitesi, Eğitim ve Araştırma Hastanesi, Tıbbi Onkoloji
• Altınbaş Üniversitesi Medical Park Bahçelievler Hastanesi, Tıbbi Onkoloji 
• İstinye Üniversite Hastanesi Liv Hospital Bahçeşehir

Mesleki Üyelikler

• Türk İç Hastalıkları Uzmanlık Derneği
• Türk Tıbbi Onkoloji Derneği
• European Society for Medical Oncology
• American Society for Clinical Oncology

• 1. Duzkopru Y, Cilbir E, Imamoglu GI, Dogan O, Eren T. Second-line Chemotherapy in Advanced Gastric Cancer: Taxanes versus 5-FU-Based Treatment. Age. 2023;60:60.
• 2. Duzkopru Y, Kocanoglu A, Dogan O, Sahinli H, Cilbir E, Altinbas M. Hemoglobin, albumin, lymphocyte, and platelet score as a predictor of prognosis in metastatic gastric cancer. World Journal of Gastrointestinal Oncology. 2023;15(9):1626.
• 3. Akhanlı P, Hepşen S, Kayhan S, Doğan Ö, Düzköprü Y, Çakal E. Prevalence of adrenal incidentaloma in patients performed thorax computed tomography for suspected COVID-19 infection. Journal of Health Sciences and Medicine. 2021;6(5):1105-1108.
• 4. Dogan O, Sahinli H, Duzkopru Y, Akdag T, Kocanoglu A. Is sarcopenia effective on survival in patients with metastatic gastric cancer? World Journal of Gastrointestinal Oncology. 2024;16(5):1861.
• 5. Duzkopru Y, Eren T, Kocanoglu A, Dogan O, Isak O, Ergun O. Factors affecting survival in patients undergoing percutaneous transhepatic biliary drainage for malignant biliary obstruction. Eur Rev Med Pharmacol Sci. 2024;28(4):1554-1561.
• 6. Duzkopru Y, Kocanoglu A, Yigitbay M, Dogan O, Sahinli H, Yazilitas D. Analyzing HALP and PNI scores as prognostic factors in metastatic head and neck cancers. Asian Journal of Surgery. 2024;47(12):5101-5105.
• 7. Kahraman S, Erul E, Gumusay O, et al. Real-world treatment efficacy of ribociclib or palbociclib plus fulvestrant in hormone receptor-positive/HER2-negative metastatic breast cancer: Turkish Oncology Group (TOG) Study. Clinical Breast Cancer. 2025;
• 8. Kahraman S, Hizal M, Demirel BC, et al. Activity of CDK4/6 inhibitors and parameters affecting survival in elderly patients in age-subgroups: Turkish Oncology Group (TOG) retrospective study. BMC cancer. 2024;24(1):1592.
• 9. Uzun S, Cebeci E, Dogan O, et al. Comparison of lower and upper limb remote ischemic preconditioning to prevent contrast-induced nephropathy: a randomized pilot study with a control group. Revista de nefrología, diálisis y transplante. 2022;42(4):296-306.